Clinical Trial Update: Primary Care iSBIRT to Reduce Serious Teen Health Risks [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of iSBIRT to reduce teen risk behaviors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Substance Use Disorder

Drugs mentioned

• iSBIRT

Snippet

Sponsor: Boston Children's Hospital | Conditions: Substance-related Disorders, Depression | Phase 1, Phase 2 | Status: WITHDRAWN